We’re In! GelSana Therapeutics, Inc. Joins the 2025 MedTech Innovator … Read More
Melissa Krebs Inducted into the American Institute of Medical and Biological Engineering (AIMBE) College of Fellows
Melissa Krebs, CEO, has been inducted into the American Institute … Read More
GelSana Awarded Another Phase I SBIR from NIDDK
GelSana is proud to announce that we have been awarded … Read More
GelSana Adds Commercialization Expertise with New Board Director, Diana Verrilli
GelSana, an Innosphere Ventures client company, today announced that Diana Verrilli, Chief … Read More
GelSana Hires Chief Operating Officer, Jon Fernandez, to Drive Commercialization and Operations Growth
(AURORA, CO) – May 7, 2024 – GelSana, an Innosphere Ventures … Read More
GelSana Awarded an AFWERX Phase II SBIR Contract to Develop Novel Polymers for Enhanced Wound Healing in Combat-Related Burn Injuries
(AURORA, CO) – April 10, 2024 – GelSana announces it has … Read More
GelSana Wins Inaugural Mines Venture Fund I Investment
(GOLDEN, CO) – February 19, 2024 – GelSana Therapeutics, a … Read More
GelSana Announces Initial Close on Second Seed Priced Round
Thrilled to announce the initial close on our second Seed … Read More
GelSana Selected to Present at Silicon Valley Leaders Forum HealthTech Showcase, November 2023
GelSana was honored to be selected as one of the … Read More
GelSana Pitches at Media Pitch Day at Fitzsimons Innovation Community
GelSana was selected as one of the companies to pitch … Read More